Bacillus Calmette–Guérin Immunotherapy for Cancer

Bacillus Calmette–Guérin (BCG), an attenuated vaccine from Mycobacterium bovis, was initially developed as an agent for vaccination against tuberculosis. BCG proved to be the first successful immunotherapy against established human bladder cancer and other neoplasms. The use of BCG has been shown to...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Vaccines (Basel)
Prif Awduron: Cardillo, Fabíola, Bonfim, Maiara, da Silva Vasconcelos Sousa, Periela, Mengel, José, Ribeiro Castello-Branco, Luiz Roberto, Pinho, Rosa Teixeira
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2021
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8147207/
https://ncbi.nlm.nih.gov/pubmed/34062708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9050439
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg